Interferon-γ-producing immature myeloid cells confer protection against severe invasive group A Streptococcus infections

Nature Communications

Volumn 3, Issue , 2012, Pages

  Matsumura, Takayuki ^a   Ato, Manabu ^a   Ikebe, Tadayoshi ^a   Ohnishi, Makoto ^a   Watanabe, Haruo ^a   Kobayashi, Kazuo ^a  

^a NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; NITRIC OXIDE; CD11B ANTIGEN; CYTOKINE; HOMEODOMAIN PROTEIN; IMMUNOGLOBULIN G; RAG 1 PROTEIN; RAG-1 PROTEIN;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIUM ISOLATE; BIOSYNTHESIS; BONE MARROW CELL; CELL STRUCTURE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE SEVERITY; GROUP A STREPTOCOCCAL INFECTION; HEMATOPOIETIC STEM CELL; HOST RESISTANCE; IMMATURE MYELOID CELL; INFECTION RESISTANCE; MALE; MOUSE; NEUTROPENIA; NEUTROPHIL; NONHUMAN; PROTEIN BLOOD LEVEL; STREPTOCOCCUS GROUP A; ANIMAL; BLOOD; C3H MOUSE; C57BL MOUSE; CELL DIFFERENTIATION; CELL NUCLEUS; CHEMISTRY; CYTOLOGY; GENETICS; GENOTYPE; IMMUNE SYSTEM; METABOLISM; RAT; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PYOGENES; TRANSGENIC MOUSE;

MUS; STREPTOCOCCUS SP. 'GROUP A';

ANIMALS; ANTIGENS, CD11B; BONE MARROW CELLS; CELL DIFFERENTIATION; CELL NUCLEUS; CYTOKINES; GENOTYPE; HOMEODOMAIN PROTEINS; IMMUNE SYSTEM; IMMUNOGLOBULIN G; INTERFERON-GAMMA; MICE; MICE, INBRED C3H; MICE, INBRED C57BL; MICE, TRANSGENIC; MYELOID CELLS; NEUTROPENIA; NEUTROPHILS; NITRIC OXIDE; RATS; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS PYOGENES;

EID: 84857778679     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms1677     Document Type: Article

References (46)

1. Lappin, E. & Ferguson, A. J. Gram-positive toxic shock syndromes. Lancet Infect. Dis. 9, 281-290 (2009).
2. Cunningham, M. W. Pathogenesis of group A streptococcal infections. Clin. Microbiol. Rev. 13, 470-511 (2000). (Pubitemid 30452618)
3. Davies, H. D et al. Invasive group A streptococcal infections in Ontario, Canada. Ontario Group A Streptococcal Study Group. N. Engl. J. Med. 335, 547-554 (1996). (Pubitemid 26272309)
4. Bisno, A. L. & Stevens, D. L. Streptococcal infections of skin and sof tissues. N. Engl. J. Med. 334, 240-245 (1996). (Pubitemid 26030675)
5. Raeder, R. H., Barker-Merrill, L., Lester, T., Boyle, M. D. & Metzger, D. W. A pivotal role for interferon-gamma in protection against group A streptococcal skin infection. J. Infect. Dis. 181, 639-645 (2000). (Pubitemid 30131833)
6. Stavem, P., Hjort, P. F., Vogt, E. & van der Hagen, C. B. Ring-shaped nuclei of granulocytes in a patient with acute erythroleukaemia. Scand. J. Haematol. 6, 31-32 (1969).
7. Langenhuijsen, M. M. Neutrophils with ring-shaped nuclei in myeloproliferative disease. Br. J. Haematol. 58, 227-230 (1984). (Pubitemid 14002095)
8. Biermann, H. et al. Murine leukocytes with ring-shaped nuclei include granulocytes, monocytes, and their precursors. J. Leukoc. Biol. 65, 217-231 (1999). (Pubitemid 29077015)
9. Rossner, S. et al. Myeloid dendritic cell precursors generated from bone marrow suppress T cell responses via cell contact and nitric oxide production in vitro. Eur. J. Immunol. 35, 3533-3544 (2005). (Pubitemid 43025534)
10. Dardalhon, V. et al. Tim-3/galectin-9 pathway: regulation of T1 immunity through promotion of CD11b+Ly-6G+ myeloid cells. J. Immunol. 185, 1383-1392 (2010).
11. Movahedi, K. et al. Identifcation of discrete tumor-induced myeloid-derived suppressor cell subpopulations with distinct T cell-suppressive activity. Blood 111, 4233-4244 (2008).
12. Youn, J. I., Nagaraj, S., Collazo, M. & Gabrilovich, D. I. Subsets of myeloid-derived suppressor cells in tumor-bearing mice. J. Immunol. 181, 5791-5802 (2008).
13. Ribechini, E., Greifenberg, V., Sandwick, S. & Lutz, M. B. Subsets, expansion and activation of myeloid-derived suppressor cells. Med. Microbiol. Immunol. 199, 273-281 (2010).
14. Medina, E., Goldmann, O., Rohde, M., Lengeling, A. & Chhatwal, G. S. Genetic control of susceptibility to group A streptococcal infection in mice. J. Infect. Dis. 184, 846-852 (2001). (Pubitemid 32881088)
15. Goldmann, O., Chhatwal, G. S. & Medina, E. Immune mechanisms underlying host susceptibility to infection with group A streptococci. J. Infect. Dis. 187, 854-861 (2003). (Pubitemid 36286947)
16. Goldmann, O. et al. The role of the MHC on resistance to group a streptococci in mice. J. Immunol. 175, 3862-3872 (2005). (Pubitemid 41292046)
17. Goldmann, O., Chhatwal, G. S. & Medina, E. Contribution of natural killer cells to the pathogenesis of septic shock induced by Streptococcus pyogenes in mice. J. Infect. Dis. 191, 1280-1286 (2005).
18. Ikebe, T. et al. Highly frequent mutations in negative regulators of multiple virulence genes in group A streptococcal toxic shock syndrome isolates. PLoS Pathog. 6, e1000832 (2010).
19. Arad, G., Levy, R., Hillman, D. & Kaempfer, R. Superantigen antagonist protects against lethal shock and defnes a new domain for T-cell activation. Nat. Med. 6, 414-421 (2000). (Pubitemid 30208158)
20. Norrby-Teglund, A. et al. Evidence for superantigen involvement in severe group a streptococcal tissue infections. J. Infect. Dis. 184, 853-860 (2001). (Pubitemid 32881089)
21. Kotb, M. et al. An immunogenetic and molecular basis for diferences in outcomes of invasive group A streptococcal infections. Nat. Med. 8, 1398-1404 (2002). (Pubitemid 36019425)
22. Liu, F. & Whitton, J. L. Cutting edge: re-evaluating the in vivo cytokine responses of CD8+ T cells during primary and secondary viral infections. J. Immunol. 174, 5936-5940 (2005). (Pubitemid 40663779)
23. Sun, J., Madan, R., Karp, C. L. & Braciale, T. J. Efector T cells control lung infammation during acute infuenza virus infection by producing IL-10. Nat. Med. 15, 277-284 (2009).
24. Nooh, M. M., El-Gengehi, N., Kansal, R., David, C. S. & Kotb, M. HLA transgenic mice provide evidence for a direct and dominant role of HLA class II variation in modulating the severity of streptococcal sepsis. J. Immunol. 178, 3076-3083 (2007). (Pubitemid 46333188)
25. Abdeltawab, N. F. et al. An unbiased systems genetics approach to mapping genetic loci modulating susceptibility to severe streptococcal sepsis. PLoS Pathog. 4, e1000042 (2008).
26. Mombaerts, P. et al. RAG-1-defcient mice have no mature B and T lymphocytes. Cell 68, 869-877 (1992).
27. Ato, M., Ikebe, T., Kawabata, H., Takemori, T. & Watanabe, H. Incompetence of neutrophils to invasive group A streptococcus is attributed to induction of plural virulence factors by dysfunction of a regulator. PLoS One 3, e3455 (2008).
28. Eriksson, B. K., Andersson, J., Holm, S. E. & Norgren, M. Epidemiological and clinical aspects of invasive group A streptococcal infections and the streptococcal toxic shock syndrome. Clin. Infect. Dis. 27, 1428-1436 (1998). (Pubitemid 29242417)
29. Iwasaki, H. et al. Identifcation of eosinophil lineage-committed progenitors in the murine bone marrow. J. Exp. Med. 201, 1891-1897 (2005). (Pubitemid 41002925)
30. Angulo, I. et al. Involvement of nitric oxide in bone marrow-derived natural suppressor activity. Its dependence on IFN-gamma. J. Immunol. 155, 15-26 (1995).
31. Angulo, I. et al. Early myeloid cells are high producers of nitric oxide upon CD40 plus IFN-gamma stimulation through a mechanism dependent on endogenous TNF-alpha and IL-1alpha. Eur. J. Immunol. 30, 1263-1271 (2000). (Pubitemid 30311954)
32. Pelaez, B., Campillo, J. A., Lopez-Asenjo, J. A. & Subiza, J. L. Cyclophosphamide induces the development of early myeloid cells suppressing tumor cell growth by a nitric oxide-dependent mechanism. J. Immunol. 166, 6608-6615 (2001). (Pubitemid 32467201)
33. Campillo, J. A., Pelaez, B., Angulo, I., Bensussan, A. & Subiza, J. L. Involvement of IFNbeta on IFNgamma and nitric oxide (NO) production by bone marrow (BM) cells in response to lipopolysaccharide. Biomed. Pharmacother. 60, 541-547 (2006). (Pubitemid 44635085)
34. Gallina, G. et al. Tumors induce a subset of infammatory monocytes with immunosuppressive activity on CD8+ T cells. J. Clin. Invest. 116, 2777-2790 (2006). (Pubitemid 44511641)
35. Belyaev, N. N. et al. Induction of an IL7-R(+)c-Kit(hi) myelolymphoid progenitor critically dependent on IFN-gamma signaling during acute malaria. Nat. Immunol. 11, 477-485 (2010).
36. Serbina, N. V., Jia, T., Hohl, T. M. & Pamer, E. G. Monocyte-mediated defense against microbial pathogens. Annu. Rev. Immunol. 26, 421-452 (2008). (Pubitemid 351600381)
37. Metcalf, D. & Nicola, N. A. Proliferative efects of purifed granulocyte colony-stimulating factor (G-CSF) on normal mouse hemopoietic cells. J. Cell. Physiol. 116, 198-206 (1983). (Pubitemid 13034192)
38. Hitoshi, Y. et al. Distribution of IL-5 receptor-positive B cells. Expression of IL-5 receptor on Ly-1(CD5)+ B cells. J. Immunol. 144, 4218-4225 (1990). (Pubitemid 20187760)
39. Lee, J. J. & McGarry, M. P. When is a mouse basophil not a basophil? Blood 109, 859-861 (2007). (Pubitemid 46220627)
40. Delano, M. J. et al. MyD88-dependent expansion of an immature GR-1(+) CD11b(+) population induces T cell suppression and T2 polarization in sepsis. J. Exp. Med. 204, 1463-1474 (2007). (Pubitemid 46919883)
41. Zhan, Y., Lieschke, G. J., Grail, D., Dunn, A. R. & Cheers, C. Essential roles for granulocyte-macrophage colony-stimulating factor (GM-CSF) and G-CSF in the sustained hematopoietic response of Listeria monocytogenes-infected mice. Blood 91, 863-869 (1998). (Pubitemid 28078288)
42. Baldridge, M. T., King, K. Y., Boles, N. C., Weksberg, D. C. & Goodell, M. A. Quiescent haematopoietic stem cells are activated by IFN-gamma in response to chronic infection. Nature 465, 793-797 (2010).
43. Trottier, M. D., Newsted, M. M., King, L. E. & Fraker, P. J. Natural glucocorticoids induce expansion of all developmental stages of murine bone marrow granulocytes without inhibiting function. Proc. Natl Acad. Sci. USA 105, 2028-2033 (2008). (Pubitemid 351439459)
44. Breiman, R. F. et al. Defning the group A streptococcal toxic shock syndrome. Rationale and consensus defnition. JAMA 269, 390-391 (1993).
45. Dalton, D. K. et al. Multiple defects of immune cell function in mice with disrupted interferon-gamma genes. Science 259, 1739-1742 (1993). (Pubitemid 23114658)
46. Dyer, K. D. et al. Functionally competent eosinophils diferentiated ex vivo in high purity from normal mouse bone marrow. J. Immunol. 181, 4004-4009 (2008).